NME Mid-Year Report: Approvals Might Near Record With Strong 2nd Half
Executive Summary
CDER approved 23 new drugs in the first half of 2017, topping the 22 approved in all 2016; there are at least 18 products in CDER's pipeline with a user fee date this year.
You may also be interested in...
US FDA Likely To Shatter Novel Approval Record In 2018
With at least 40 pending novel products, FDA seems poised to break its 2017 approval record of 46, and could even reach 60.
Priority Review Designations In US: Third Quarter Spike Continues In 2017
Third quarter saw record total of 26 announcements for priority review designations; drop-off now likely.
Keeping Track: Cardio, Antibiotic Approvals Put FDA Over Last Year's Novel Drug Count
The latest drug development news and US FDA highlights from our Performance Tracker.